Glenn Cornett

Glenn Cornett's work experience includes serving as the Chairman and Founder of Cogmotos, Inc., a company focused on developing assets for the prevention and treatment of postoperative delirium. Glenn also holds the role of Chairman and Partner at mplexity, a holding company managing equity interests in biotechnology companies and providing advisory services. Additionally, Cornett is a Co-Founder and Advisor/Chief Science Officer at Kurve Therapeutics, a clinical-stage company specializing in Alzheimer's disease and other neurodegenerative disorders.

In previous roles, Cornett worked as a Vice President and Strategy Practice Lead at Razorfish, where they developed product/service offerings and established client relationships. Glenn also served as a Manager of Corporate Research Strategy at Eli Lilly, overseeing strategy, marketing, and sales activities. Prior to that, Cornett worked as a Consultant at McKinsey, specializing in strategic consulting, and as a Consultant at Los Alamos National Laboratory, focusing on policy analysis and applied aerosol science.

Overall, Cornett's experience spans various industries and roles, including entrepreneurship, biotechnology, strategy development, and consulting.

Glenn Cornett completed their education in a chronological order. Glenn began by attending Allen Park High School from 1976 to 1979, where they received their High School Diploma. Glenn then enrolled at Brigham Young University from 1979 to 1985, earning a Bachelor of Arts degree with University Honors in Chemistry. Following this, they attended the University of Michigan Medical School from 1985 to 1994, where they obtained their MD degree in Medicine. Concurrently, from 1987 to 1991, they pursued a PhD in Neuroscience at UCLA.